Abstract
Conventional methods for gene delivery with non-viral or viral delivery carriers are beset with various disadvantages such as immune reactions, low transfection efficiency, and toxicity. Innumerable methods are under investigation to help improve the development of biodegradable polymers with low cytotoxicity, transcellular transport ability, favorable physicochemical properties, ease of modification by targeting ligands, and high transfection efficiency. Chitosan is a biodegradable polymer that has attained a lot of attention as a gene delivery vector due to its ease of modification, high transfection efficiency, and exceptional biocompatibility. Chitosan being cationic in nature can form polyelectrolyte complexes with negatively charged DNA allowing nucleic acid condensation along with protection from nucleases, which is widely beneficial in gene therapies. Moreover, factors such as pH, degree of acetylation, N/P ratio, and surface modifications can be suitably investigated to improve transfection efficiency of chitosan-based vectors. Various chitosan-based gene delivery systems developed in the past decade including chitosan-based polyplexes, nanoparticles, and DNA vaccines have been discussed in this chapter. The goal of this book chapter is to review recent advancements in gene therapy with major focus on chitosan and its applications as a gene delivery vector.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agirre M, Zarate J, Puras G, Ojeda E, Pedraz JL (2015) Improving transfection efficiency of ultrapure oligochitosan/DNA polyplexes by medium acidification. Drug Deliv 22:100–110
Ahmad M, Manzoor K, Ikram S (2018) Applications of nanocomposite materials in drug delivery. Woodhead Publishing, Cambridge, MA, pp 27–38. https://doi.org/10.1016/B978-0-12-813741-3.00002-9
Aiuti A et al (2009) Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 360:447–458
Aiuti A et al (2013) Lentiviral hematopoietic stem cell gene therapy in patients with wiskott-Aldrich syndrome. Science (80-) 341:1233151
Alameh M et al (2018) SiRNA delivery with chitosan: influence of chitosan molecular weight, degree of deacetylation, and amine to phosphate ratio on in vitro silencing efficiency, hemocompatibility, biodistribution, and in vivo efficacy. Biomacromolecules 19:112–131
Al-dosari MS, Gao X (2009) Nonviral gene delivery: principle, limitations, and recent progress. AAPS J 11:671–681
Alton EWFW et al (2013) A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis. Thorax 68:1075–1077
Aspden TJ et al (1997) Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J Pharm Sci. https://doi.org/10.1021/js960182o
Badding MA, Vaughan EE, Dean DA (2012) Transcription factor plasmid binding modulates microtubule interactions and intracellular trafficking during gene transfer. Gene Ther. https://doi.org/10.1038/gt.2011.96
Badding MA, Lapek JD, Friedman AE, Dean DA (2013) Proteomic and functional analyses of protein-DNA complexes during gene transfer. Mol Ther. https://doi.org/10.1038/mt.2012.231
Baghdan E et al (2018) Lipid coated chitosan-DNA nanoparticles for enhanced gene delivery. Int J Pharm 535:473–479
Bao S, Thrall BD, Gies RA, Miller DL (1998) In vivo transfection of melanoma cells by lithotripter shock waves. Cancer Res
Bashyal S, Noh G, Keum T, Choi YW, Lee S (2016) Cell penetrating peptides as an innovative approach for drug delivery; then, present and the future. J Pharm Investig 46:205–220
Bekeredjian R, Grayburn PA, Shohet RV (2005) Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2004.08.067
Bett AJ, Haddara W, Prevec L, Graham FL (1994) An efficient and flexible system for construction of adenovirus vectors with insertions or deletions in early regions 1 and 3. Proc Natl Acad Sci U S A 91:8802–8806
Blaese RM et al (1995) T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (80-) 270:475–480
Boonthum C et al (2018) Gonadotropin-releasing hormone-modified chitosan as a safe and efficient gene delivery vector for spermatogonia cells. Reprod Domest Anim 53:23–28
Boussif O et al (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci. https://doi.org/10.1073/pnas.92.16.7297
Brentjens RJ et al (2013) CD19-targeted T cells rapidly induce molecular remissions in adults with chemotherapy-refractory acute lymphoblastic leukemia. Sci Transl Med 5:177ra38
Breunig M, Lungwitz U, Liebl R, Goepferich A (2007) Breaking up the correlation between efficacy and toxicity for nonviral gene delivery. Proc Natl Acad Sci. https://doi.org/10.1073/pnas.0703882104
Breunig M et al (2008) Mechanistic investigation of poly(ethylene imine)-based siRNA delivery: disulfide bonds boost intracellular release of the cargo. J Control Release. https://doi.org/10.1016/j.jconrel.2008.05.016
Buchbinder SP et al (2008) Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the step study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet. https://doi.org/10.1016/S0140-6736(08)61591-3
Burton EA, Bai Q, Goins WF, Glorioso JC (2002) Replication-defective genomic herpes simplex vectors: design and production. Curr Opin Biotechnol 13:424–428
Buschmann MD et al (2013) Chitosans for delivery of nucleic acids. Adv Drug Deliv Rev. https://doi.org/10.1016/j.addr.2013.07.005
Buys MG, Plessis L, Marais A, Kotzé A, Hamman J (2013) Direct compression of chitosan: process and formulation factors to improve powder flow and tablet performance. Curr Drug Deliv 10:348–356
Cao W et al (2005) Effects of the degree of deacetylation on the physicochemical properties and Schwann cell affinity of chitosan films. J Biomater Appl 20:157–177
Carpentier AC et al (2012) Effect of alipogene tiparvovec (aav1-lpls447x) on postprandial chylomicron metabolism in lipoprotein lipase-deficient patients. J Clin Endocrinol Metab 97:1635–1644
Cassaday RD et al (2007) A phase I study of immunization using particle-mediated epidermal delivery of genes for gp100 and GM-CSF into uninvolved skin of melanoma patients. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-06-2039
Cauchie HM (2002) Chitin production by arthropods in the hydrosphere. Hydrobiologia. https://doi.org/10.1023/A:1015615819301
Cavazzana-Calvo M et al (2010) Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia. Nature 467:318–322
Chang KL, Higuchi Y, Kawakami S, Yamashita F, Hashida M (2011) Development of lysine-histidine dendron modified chitosan for improving transfection efficiency in HEK293 cells. J Control Release 156:195–202
Chatelet C, Damour O, Domard A (2001) Influence of the degree of acetylation on some biological properties of chitosan films. Biomaterials 22:261–268
Chen S et al (2006) Efficient gene delivery to pancreatic islets with ultrasonic microbubble destruction technology. Proc Natl Acad Sci. https://doi.org/10.1073/pnas.0602921103
Chen J, Guo Z, Tian H, Chen X (2016) Production and clinical development of nanoparticles for gene delivery. Mol Ther – Methods Clin Dev 3:16023
Cheung RCF, Ng TB, Wong JH, Chan WY (2015) Chitosan: an update on potential biomedical and pharmaceutical applications. Mar Drugs 13:5156–5186
Chiu SJ, Ueno NT, Lee RJ (2004) Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin®) conjugated polyethylenimine. J Control Release. https://doi.org/10.1016/j.jconrel.2004.03.019
Choate KA, Khavari PA (1997) Direct cutaneous gene delivery in a human genetic skin disease. Hum Gene Ther. https://doi.org/10.1089/hum.1997.8.14-1659
Chung MJ, Park JK, Park YI (2012) Anti-inflammatory effects of low-molecular weight chitosan oligosaccharides in IgE–antigen complex-stimulated RBL-2H3 cells and asthma model mice. Int Immunopharmacol 12:453–459
Cifuentes-Rius A et al (2017) In vivo fate of carbon nanotubes with different physicochemical properties for gene delivery applications. ACS Appl Mater Interfaces 9:11461–11471
Coll J-L et al (1999) In vivo delivery to tumors of DNA complexed with linear Polyethylenimine. Hum Gene Ther. https://doi.org/10.1089/10430349950017662
Collins M, Thrasher A (2015) Gene therapy: progress and predictions. Proc R Soc B Biol Sci 282:20143003
Coma V, Deschamps A, Martial-Gros A (2003) Bioactive packaging materials from edible chitosan polymer – antimicrobial activity assessment on dairy-related contaminants. J Food Sci. https://doi.org/10.1111/j.1365-2621.2003.tb05806.x
Corbet C et al (2016) Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: identification of an optimal combination of ligand structure, linker and grafting method. J Control Release. https://doi.org/10.1016/j.jconrel.2015.12.020
Corsi K, Chellat F, Yahia L, Fernandes JC (2003) Mesenchymal stem cells, MG63 and HEK293 transfection using chitosan-DNA nanoparticles. Biomaterials. https://doi.org/10.1016/S0142-9612(02)00507-0
Danthinne X, Imperiale MJ (2000) Production of first generation adenovirus vectors: a review. Gene Ther 7:1707–1714
Daya S, Berns KI (2008) Gene therapy using adeno-associated virus vectors. Clin Microbiol Rev 21:583–593
De Figueiredo IR, Freire JM, Flores L, Veiga AS, Castanho MARB (2014) Cell-penetrating peptides: a tool for effective delivery in gene-targeted therapies. IUBMB Life 66:182–194
Dean DA (1997) Import of plasmid DNA into the nucleus is sequence specific. Exp Cell Res. https://doi.org/10.1006/excr.1996.3427
Deng R-H, Qiu B, Zhou P-H (2018) Chitosan/hyaluronic acid/plasmid-DNA nanoparticles encoding interleukin-1 receptor antagonist attenuate inflammation in synoviocytes induced by interleukin-1 beta. J Mater Sci Mater Med 29:155
DePolo NJ et al (2000) VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum. Mol Ther 2:218–222
Deptuch T, Dams-Kozlowska H (2017) Silk materials functionalized via genetic engineering for biomedical applications. Materials (Basel) 10:1–21
Diebold Y et al (2007) Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials. https://doi.org/10.1016/j.biomaterials.2006.11.028
Ding Y et al (2014) Gold nanoparticles for nucleic acid delivery. Mol Ther 22:1075–1083
Dizaj SM, Jafari S, Khosroushahi AY (2014) A sight on the current nanoparticle-based gene delivery vectors. Nanoscale Res Lett 9:1–9
Dodane V, Amin Khan M, Merwin JR (1999) Effect of chitosan on epithelial permeability and structure. Int J Pharm 182:21–32
dos Santos Rodrigues B, Oue H, Banerjee A, Kanekiyo T, Singh J (2018) Dual functionalized liposome-mediated gene delivery across triple co-culture blood brain barrier model and specific in vivo neuronal transfection. J Control Release 286:264–278
Dowty ME, Williams P, Zhang G, Hagstrom JE, Wolff JA (1995) Plasmid DNA entry into postmitotic nuclei of primary rat myotubes. PNAS. https://doi.org/10.1073/pnas.92.10.4572
Drape RJ et al (2006) Epidermal DNA vaccine for influenza is immunogenic in humans. Vaccine. https://doi.org/10.1016/j.vaccine.2005.08.012
El-Hefian EA, Elgannoudi ES, Mainal A, Yahaya AH (2010) Characterization of chitosan in acetic acid: rheological and thermal studies. Turk J Chem 34:47–56
Epstein AL (2009) Progress and prospects: biological properties and technological advances of herpes simplex virus type 1-based amplicon vectors. Gene Ther 16:709–715
Fang N, Chan V, Mao HQ, Leong KW (2001) Interactions of phospholipid bilayer with chitosan: effect of molecular weight and pH. Biomacromolecules. https://doi.org/10.1021/bm015548s
Felgner PL et al (1987) Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci. https://doi.org/10.1073/pnas.84.21.7413
Flotte TR (2004) Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors. Gene Ther 11:805–810
Fraley R, Subramani S, Berg P, Papahadjopoulos D (1980) Introduction of liposome-encapsulated SV40 DNA into cells. J Biol Chem. https://doi.org/10.1016/j.carbpol.2010.11.047
Funkhouser JD, Aronson NN (2007) Chitinase family GH18: evolutionary insights from the genomic history of a diverse protein family. BMC Evol Biol 7:1–16
Gao S et al (2003) Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. Int J Pharm. https://doi.org/10.1016/S0378-5173(03)00082-6
Gao Y et al (2008) Arginine-chitosan/DNA self-assemble nanoparticles for gene delivery: in vitro characteristics and transfection efficiency. Int J Pharm. https://doi.org/10.1016/j.ijpharm.2008.03.037
Glasspool-Malone J, Malone RW (1999) Marked enhancement of direct respiratory tissue transfection by Aurintricarboxylic acid. Hum Gene Ther. https://doi.org/10.1089/10430349950017707
Gonçalves GAR, Paiva RMA (2017) Gene therapy: advances, challenges and perspectives. Einstein (São Paulo) 15:369–375
Goula D et al (1998) Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther. https://doi.org/10.1038/sj.gt.3300717
Guidotti G, Brambilla L, Rossi DC-PP (2017) From basic research to clinics. Trends Pharmacol Sci 38:406–424
Guliyeva U, Oner F, Ozsoy S, Haziroglu R (2006) Chitosan microparticles containing plasmid DNA as potential oral gene delivery system. Eur J Pharm Biopharm 62:17–25
Gupta S et al (2018) Novel combination BMP7 and HGF gene therapy instigates selective myofibroblast apoptosis and reduces corneal haze in vivo. Investig Ophthalmol Vis Sci 59:1045–1057
Gurunathan S, Klinman DM, Seder RA (2000) DNA vaccines: immunology, application, and optimization. Annu Rev Immunol 18:927–974
Habib NA et al (1996) Preliminary report: the short-term effects of direct p53 DNA injection in primary hepatocellular carcinomas. Cancer Detect Prev 20:103–107
Hacein-Bey-Abina S et al (2008) Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest 118:3132–3142
Hafner A, Dürrigl M, Pepić I, Filipović-Grčić J (2011) Short- and long-term stability of lyophilised melatonin-loaded lecithin/chitosan nanoparticles. Chem Pharm Bull (Tokyo) 59:1117–1123
Hao QZ, Hen JC, Cai-xia HE, Ang GT (2009) N-P ratio significantly influences the transfection efficiency and cytotoxicity of a PEI-chitosan-DNA complex.pdf. Biol Pharm Bull 32:706–710
Hardee CL, Arévalo-Soliz LM, Hornstein BD, Zechiedrich L (2017) Advances in non-viral DNA vectors for gene therapy. Genes (Basel) 8
Harding SE (2010) Some observations on the effects of bioprocessing on biopolymer stability. J Drug Target 18:732–740
Harish Prashanth KV, Tharanathan RN (2007) Chitin/chitosan: modifications and their unlimited application potential-an overview. Trends Food Sci Technol. https://doi.org/10.1016/j.tifs.2006.10.022
Heller LC, Ugen K, Heller R (2005) Electroporation for targeted gene transfer. Expert Opin Drug Deliv 2:255–268
Hermonat PL, Muzyczka N (1984) Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells. Proc Natl Acad Sci U S A 81:6466–6470
Hersey P, Gallagher S (2014) Intralesional immunotherapy for melanoma. J Surg Oncol. https://doi.org/10.1002/jso.23494
Herweijer H, Wolff JA (2003) Progress and prospects: naked DNA gene transfer and therapy. Gene Ther 10:453–458
Hickman MA et al (1994) Gene expression following direct injection of DNA into liver 915. Hum Gene Ther. https://doi.org/10.1089/hum.1994.5.12-1477
Hill AVS et al (2010) Prime-boost vectored malaria vaccines: Progress and prospects. Hum Vaccin 6:78–83
Hirano S et al (1991) Enhancement of serum lysozyme activity by injecting a mixture of chitosan oligosaccharides intravenously in rabbits. Agric Biol Chem 55:2623–2625
Hood JD et al (2002) Tumor regression by targeted gene delivery to the neovasculature. Science (80-). https://doi.org/10.1126/science.1070200
Hou CC et al (2005) Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-β signaling and fibrosis in rat remnant kidney. Am J Pathol. https://doi.org/10.1016/S0002-9440(10)62297-3
Howard KA et al (2009) Chitosan/siRNA nanoparticle–mediated TNF-α knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model. Mol Ther 17:162–168
Hu J et al (2016) A biodegradable polyethylenimine-based vector modified by trifunctional peptide R18 for enhancing gene transfection efficiency in vivo. PLoS One 11:1–21
Huang M, Fong CW, Khor E, Lim LY (2005) Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. J Control Release 106:391–406
Huber PE, Jenne J, Debus J, Wannenmacher MF, Pfisterer P (1999) A comparison of shock wave and sinusoidal-focused ultrasound-induced localized transfection of HeLa cells. Ultrasound Med Biol. https://doi.org/10.1016/S0301-5629(99)00099-X
Hynynen K, McDannold N, Martin H, Jolesz FA, Vykhodtseva N (2003) The threshold for brain damage in rabbits induced by bursts of ultrasound in the presence of an ultrasound contrast agent (Optison®). Ultrasound Med Biol. https://doi.org/10.1016/S0301-5629(02)00741-X
Ibraheem D, Elaissari A, Fessi H (2014) Gene therapy and DNA delivery systems. Int J Pharm 459:70–83
Illum L (1998) Chitosan and its use as a pharmaceutical excipient. Pharm Res. https://doi.org/10.1023/A:1011929016601
Issa MM et al (2006) Targeted gene delivery with trisaccharide-substituted chitosan oligomers in vitro and after lung administration in vivo. J Control Release. https://doi.org/10.1016/j.jconrel.2006.06.029
Jayakumar R et al (2010) Chitosan conjugated DNA nanoparticles in gene therapy. Carbohydr Polym 79:1–8
Jayant RD et al (2016) Current status of non-viral gene therapy for CNS disorders HHS public access. Expert Opin Drug Deliv 13:1433–1445
Jean M et al (2009) Chitosan-plasmid nanoparticle formulations for IM and SC delivery of recombinant FGF-2 and PDGF-BB or generation of antibodies. Gene Ther 16:1097–1110
Ji J et al (2014) Chemical modifications of chitosan and its applications. Polym-Plast Technol Eng 53:1494–1505
Jiang HL et al (2008) Galactosylated poly(ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targeting. J Control Release. https://doi.org/10.1016/j.jconrel.2008.07.029
Jiang H-L, Cui P-F, Xie R-L, Cho C-S (2014) Chapter six: chemical modification of chitosan for efficient gene therapy. In: Marine carbohydrates: fundamentals and applications, part B, vol 73. Elsevier Inc., Saint Louis
Jin L, Zeng X, Liu M, Deng Y, He N (2014) Current progress in gene delivery technology based on chemical methods and nano-carriers. Theranostics. https://doi.org/10.7150/thno.6914
Jin H et al (2016) Folate-chitosan nanoparticles loaded with ursolic acid confer anti-breast cancer activities in vitro and in vivo. Sci Rep. https://doi.org/10.1038/srep30782
Jones C, Crane D, Lemercinier X, Bolgiano B, Yost S (1996) Physicochemical studies of the structure and stability of poly-saccharide-protein conjugate vaccines. Dev Biol Stand 87:143–151
JONES RA et al (2003) Poly(2-alkylacrylic acid) polymers deliver molecules to the cytosol by pH-sensitive disruption of endosomal vesicles. Biochem J. https://doi.org/10.1042/bj20021945
Kadiyala I, Loo Y, Roy K, Rice J, Leong KW (2010) Transport of chitosan-DNA nanoparticles in human intestinal M-cell model versus normal intestinal enterocytes. Eur J Pharm Sci. https://doi.org/10.1016/j.ejps.2009.11.002
Kalos M et al (2011) T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med 3:95ra73
Kam HM, Khor E, Lim LY (1999) Storage of partially deacetylated chitosan films. J Biomed Mater Res 48:881–888
Kamimura K, Suda T, Zhang G, Liu D (2011) Advances in gene delivery systems. Pharm Med 25:293–306
Katas H, Alpar HO (2006) Development and characterisation of chitosan nanoparticles for siRNA delivery. J Control Release. https://doi.org/10.1016/j.jconrel.2006.07.021
Kato Y, Onishi H, Machida Y (2003) Application of chitin and chitosan derivatives in the pharmaceutical field. Curr Pharm Biotechnol. https://doi.org/10.2174/1389201033489748
Kawabata K, Takakura Y, Hashida M (1995) The fate of plasmid DNA after intravenous injection in mice: involvement of scavenger receptors in its hepatic uptake. Pharm Res. https://doi.org/10.1023/A:1016248701505
Kean T, Thanou M (2010) Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev. https://doi.org/10.1016/j.addr.2009.09.004
Kean T, Thanou M (2011) Renewable resources for functional polymers and biomaterials: polysaccharides, proteins and polyesters, pp 327–361. https://doi.org/10.1039/9781849733519-00292
Khalil IA (2006) Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev. https://doi.org/10.1124/pr.58.1.8
Khatri K, Goyal AK, Gupta PN, Mishra N, Vyas SP (2008) Plasmid DNA loaded chitosan nanoparticles for nasal mucosal immunization against hepatitis B. Int J Pharm 354:235–241
Kiang T, Wen J, Lim HW, Leong KW (2004) The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials. https://doi.org/10.1016/j.biomaterials.2003.12.036
Kim TH, Ihm JE, Choi YJ, Nah JW, Cho CS (2003) Efficient gene delivery by urocanic acid-modified chitosan. J Control Release. https://doi.org/10.1016/j.jconrel.2003.08.017
Kim TG et al (2004) Gene transfer into human hepatoma cells by receptor-associated protein/polylysine conjugates. Bioconjug Chem 15:326–332
Kim Y-M, Park S-C, Jang M-K (2017) Targeted gene delivery of polyethyleneimine-grafted chitosan with RGD dendrimer peptide in α v β 3 integrin-overexpressing tumor cells. Carbohydr Polym 174:1059–1068
Klein TM, Sanford JC, Wolf ED, Wu R (1987) High-velocity microprojectiles for delivering nucleic acids into living cells. Nature. https://doi.org/10.1038/327070a0
Knapczyk J (1992) Antimycotic buccal and vaginal tablets with chitosan. Int J Pharm 88:9–14
Kong HJ et al (2005) Non-viral gene delivery regulated by stiffness of cell adhesion substrates. Nat Mater 4:460–464
Konstan MW et al (2004) Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum Gene Ther. https://doi.org/10.1089/hum.2004.15.ft-2
Köping-Höggård M et al (2001) Chitosan as a nonviral gene delivery system. Structure-property relationships and characteristics compared with polyethylenimine in vitro and after lung administration in vivo. Gene Ther 8:1108–1121
Kritchenkov AS, Stanislav A, Skorik YA (2017) Chitosan and its derivatives: vectors in gene therapy. Russ Chem Rev 86:231
Kumar SR, Markusic DM, Biswas M, High KA, Herzog RW (2016) Clinical development of gene therapy: results and lessons from recent successes. Mol Ther – Methods Clin Dev 3:16034
Kwon OJ, Kang E, Choi JW, Kim SW, Yun CO (2013) Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy. J Control Release 169:257–265
Laemmli UK (1975) Characterization of DNA condensates induced by poly(ethylene oxide) and polylysine. Proc Natl Acad Sci. https://doi.org/10.1073/pnas.72.11.4288
Lai WF, Lin MCM (2009) Nucleic acid delivery with chitosan and its derivatives. J Control Release. https://doi.org/10.1016/j.jconrel.2008.11.021
Lavertu M, Méthot S, Tran-Khanh N, Buschmann MD (2006) High efficiency gene transfer using chitosan/DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials 27:4815–4824
Layek B, Lipp L, Singh J (2015a) APC targeted micelle for enhanced intradermal delivery of hepatitis B DNA vaccine. J Control Release 207:143–153
Layek B, Singh J (2013) Amino acid grafted chitosan for high performance gene delivery: comparison of amino acid hydrophobicity on vector and polyplex characteristics. Biomacromolecules 14:485–494
Layek B, Lipp L, Singh J (2015b) Cell penetrating peptide conjugated chitosan for enhanced delivery of nucleic acid. Int J Mol Sci 16:28912–28930
Lee MK et al (2005) The use of chitosan as a condensing agent to enhance emulsion-mediated gene transfer. Biomaterials. https://doi.org/10.1016/j.biomaterials.2004.07.008
Lee D et al (2007) Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharm Res. https://doi.org/10.1007/s11095-006-9136-9
Lee SJ et al (2014) TNF-alpha gene silencing using polymerized siRNA/thiolated glycol chitosan nanoparticles for rheumatoid arthritis. Mol Ther 22:397–408
Leong KW et al (1998) DNA-polycation nanospheres as non-viral gene delivery vehicles. J Control Release. https://doi.org/10.1016/S0168-3659(97)00252-6
Liu Q, Muruve DA (2003) Molecular basis of the inflammatory response to adenovirus vectors. Gene Ther 10:935–940
Liu W et al (2005) An investigation on the physicochemical properties of chitosan/DNA polyelectrolyte complexes. Biomaterials. https://doi.org/10.1016/j.biomaterials.2004.07.038
Lizardi-Mendoza J, Argüelles Monal WM, Goycoolea Valencia FM (2016) Chitosan in the preservation of agricultural commodities. https://doi.org/10.1016/B978-0-12-802735-6.00001-X
Look J et al (2015) Ligand-modified human serum albumin nanoparticles for enhanced gene delivery. Mol Pharm 12:3202–3213
López FA, Mercê ALR, Alguacil FJ, López-Delgado A (2008) A kinetic study on the thermal behaviour of chitosan. J Therm Anal Calorim 91:633–639
Lu C et al (2012) Phase I clinical trial of systemically administered TUSC2(FUS1)-nanoparticles mediating functional gene transfer in humans. PLoS One 7:e34833
Lu H, Dai Y, Lv L, Zhao H (2014) Chitosan-graft-polyethylenimine/DNA nanoparticles as novel non-viral gene delivery vectors targeting osteoarthritis. PLoS One 9
Lv H, Zhang S, Wang B, Cui S, Yan J (2006) Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release. https://doi.org/10.1016/j.jconrel.2006.04.014
Ma PL, Lavertu M, Winnik M, Buschmann MD (2009) New insights into chitosan – DNA interactions using isothermal titration microcalorimetry. Biomacromolecules:1490–1499. https://doi.org/10.1021/bm900097s
MacLaughlin FC et al (1998) Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release 56:259–272
Majidi S et al (2016) Magnetic nanoparticles: applications in gene delivery and gene therapy. Artif Cells Nanomed Biotechnol 44:1186–1193
Malhotra M, Tomaro-Duchesneau C, Prakash S (2013) Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases. Biomaterials. https://doi.org/10.1016/j.biomaterials.2012.10.013
Mandke R, Singh J (2012) Cationic nanomicelles for delivery of plasmids encoding Interleukin-4 and Interleukin-10 for prevention of autoimmune diabetes in mice. Pharm Res 29:883–897
Mann R, Mulligan RC, Baltimore D (1983) Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33:153–159
Manno CS et al (2006) Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response. Nat Med. https://doi.org/10.1038/nm1358
Mansouri S et al (2004) Chitosan-DNA nanoparticles as non-viral vectors in gene therapy: strategies to improve transfection efficacy. Eur J Pharm Biopharm. https://doi.org/10.1016/S0939-6411(03)00155-3
Mao HQ et al (2001) Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release. https://doi.org/10.1016/S0168-3659(00)00361-8
Mao S, Sun W, Kissel T (2010) Chitosan-based formulations for delivery of DNA and siRNA. Adv Drug Deliv Rev. https://doi.org/10.1016/j.addr.2009.08.004
Marshall E (1999) Gene therapy death prompts review of adenovirus vector. Science (80-) 286:2244–2245
Martien R, Loretz B, Thaler M, Majzoob S, Bernkop-Schnürch A (2007) Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery? J Biomed Mater Res, Part A. https://doi.org/10.1002/jbm.a.31135
Matea CT et al (2017) Quantum dots in imaging drug delivery and sensor applications. Int J Nanomedicine 12:5421–5431
McKiernan PJ, Cunningham O, Greene CM, Cryan SA (2013) Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology. Int J Nanomedicine. https://doi.org/10.2147/IJN.S47551
McNeela EA et al (2000) A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery. Vaccine 19:1188–1198
Mease PJ et al (2009) Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor α antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study. Ann Rheum Dis. https://doi.org/10.1136/ard.2008.089375
Mendes R, Fernandes AR, Baptista PV (2017) Gold nanoparticle approach to the selective delivery of gene silencing in cancer-the case for combined delivery? Genes (Basel) 8
Messai I et al (2005) Poly(D,L-lactic acid) and chitosan complexes: interactions with plasmid DNA. Colloids Surf A Physicochem Eng Asp. https://doi.org/10.1016/j.colsurfa.2004.12.023
Miller DL, Song J (2003) Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo. Ultrasound Med Biol. https://doi.org/10.1016/S0301-5629(03)00031-0
Milletti F (2012) Cell-penetrating peptides: classes, origin, and current landscape. Drug Discov Today 17:850–860
Moss RB et al (2007) Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: a randomized placebo-controlled phase 2B trial. Hum Gene Ther. https://doi.org/10.1089/hum.2007.022
Motiei M, Kashanian S, Lucia LA, Khazaei M (2017) Intrinsic parameters for the synthesis and tuned properties of amphiphilic chitosan drug delivery nanocarriers. J Control Release. https://doi.org/10.1016/j.jconrel.2017.06.010
Mucha M, Pawlak A (2002) Complex study on chitosan degradability. Polimery/Polymers 47:509–516
Müller P et al (2016) Magnet-bead based MicroRNA delivery system to modify CD133+stem cells. Stem Cells Int 2016:90–99
Mumper RJ, Wang J, Claspell JM, Rolland A (1995) Novel polymeric condensing carriers for gene delivery. Proc Intern Symp Control Rel Bioact Mater 22:178–179
Mumper RJ et al (1996) Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle. Pharm Res. https://doi.org/10.1023/A:1016039330870
Munk M et al (2017) Using carbon nanotubes to deliver genes to hard-to-transfect mammalian primary fibroblast cells. Biomed Phys Eng Express 3
Muzzarelli R et al (1990) Antimicrobial properties of N-carboxybutyl chitosan. Antimicrob Agents Chemother 34:2019–2023
Naldini L (2015) Gene therapy returns to centre stage. Nature 526:351–360
Naldini L et al (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science (80-) 272:263–267
Nayerossadat N, Ali P, Maedeh T (2012) Viral and nonviral delivery systems for gene delivery. Adv Biomed Res 1:27
Nguyen HK et al (2000) Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents. Gene Ther. https://doi.org/10.1038/sj.gt.3301052
Nguyen TTB, Hein S, Ng CH, Stevens WF (2008) Molecular stability of chitosan in acid solutions stored at various conditions. J Appl Polym Sci 107:2588–2593
Nielsen TO (1997) Human germline gene therapy. McGill J Med 3:126–132
Nilsen-Nygaard J et al (2015) Chitosan: gels and interfacial properties. Polymers (Basel) 7:552–579
Nimesh S, Thibault MM, Lavertu M, Buschmann MD (2010) Enhanced gene delivery mediated by low molecular weight chitosan/DNA complexes: effect of pH and serum. Mol Biotechnol. https://doi.org/10.1007/s12033-010-9286-1
Nishikawa M, Huang L (2001) Nonviral vectors in the new millennium: delivery barriers in gene transfer. Hum Gene Ther 12:861–870
Noh SM et al (2010) Pegylated poly-l-arginine derivatives of chitosan for effective delivery of siRNA. J Control Release 145:159–164
Numata K, Subramanian B, Currie HA, Kaplan DL (2009) Bioengineered silk protein-based gene delivery systems. Biomaterials 30:5775–5784
O’Brien J, Lummis SCR (2002) An improved method of preparing microcarriers for biolistic transfection. Brain Res Protocol. https://doi.org/10.1016/S1385-299X(02)00175-7
Ogawa K, Yui T, Okuyama K (2004) Three D structures of chitosan. Int J Biol Macromol. https://doi.org/10.1016/j.ijbiomac.2003.11.002
Okuyama K et al (2000) Structural diversity of chitosan and its complexes. Carbohydr Polym. https://doi.org/10.1016/S0144-8617(99)00142-3
Olins DE, Olins AL, von Hippel PH (1967) Model nucleoprotein complexes: studies on the interaction of cationic homopolypeptides with DNA. J Mol Biol. https://doi.org/10.1016/0022-2836(67)90324-5
Onishi H, Machida Y (1999) Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 20:175–182
Park SW et al (2001) Intracardiac echocardiographic guidance and monitoring during percutaneous endomyocardial gene injection in porcine heart. Hum Gene Ther. https://doi.org/10.1089/104303401750195863
Park JH, Saravanakumar G, Kim K, Kwon IC (2010) Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv Drug Deliv Rev. https://doi.org/10.1016/j.addr.2009.10.003
Patel BJ, Vignesh NK, Hortelano G (2016) Chitosan DNA nanoparticles for oral gene delivery. World J Med Genet 6:22
Peng SF et al (2011) Mechanisms of cellular uptake and intracellular trafficking with chitosan/DNA/poly(γ-glutamic acid) complexes as a gene delivery vector. Biomaterials. https://doi.org/10.1016/j.biomaterials.2010.08.081
Petersen H et al (2002) Polyethylenimine-graft-poly(ethylene glycol) copolymers: influence of copolymer block structure on DNA complexation and biological activities as gene delivery system. Bioconjug Chem. https://doi.org/10.1021/bc025529v
Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic Cancer – Full Text View – ClinicalTrials.gov. Available at: https://clinicaltrials.gov/ct2/show/NCT00711997. Accessed: 25th January 2019
Phase 1/2a Study of DTA-H19 in Advanced Stage Ovarian Cancer – Full Text View – ClinicalTrials.gov. Available at: https://clinicaltrials.gov/ct2/show/NCT00826150. Accessed: 25th January 2019
Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer – Full Text View – ClinicalTrials.gov. Available at: https://clinicaltrials.gov/ct2/show/NCT00595088. Accessed: 25th January 2019
Pichon C, Billiet L, Midoux P (2010) Chemical vectors for gene delivery: uptake and intracellular trafficking. Curr Opin Biotechnol. https://doi.org/10.1016/j.copbio.2010.07.003
Qin Y et al (2011) Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals. Int J Pharm 420:304–312
Raftery R, O’Brien FJ, Cryan SA (2013) Chitosan for gene delivery and orthopedic tissue engineering applications. Molecules. https://doi.org/10.3390/molecules18055611
Ragelle H, Vandermeulen G, Préat V (2013) Chitosan-based siRNA delivery systems. J Control Release 172:207–218
Ragelle H et al (2015) Intracellular siRNA delivery dynamics of integrin-targeted, PEGylated chitosan-poly(ethylene imine) hybrid nanoparticles: a mechanistic insight. J Control Release 211:1–9
Rao SB, Sharma CP (1997) Use of chitosan as a biomaterial: studies on its safety and hemostatic potential. J Biomed Mater Res. https://doi.org/10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
Raper SE et al (2003) Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 80:148–158
Ratko TA, Cummings JP, Blebea J, Matuszewski KA (2003) Clinical gene therapy for nonmalignant disease. Am J Med 115:560–569
Regnström K, Ragnarsson EGE, Fryknäs M, Köping-Höggård M, Artursson P (2006) Gene expression profiles in mouse lung tissue after administration of two cationic polymers used for nonviral gene delivery. Pharm Res. https://doi.org/10.1007/s11095-006-9563-7
Revi D, Paul W, Anilkumar TV, Sharma CP (2014) Chitosan scaffold co-cultured with keratinocyte and fibroblast heals full thickness skin wounds in rabbit. J Biomed Mater Res, Part A 102:3273–3281
Riley M, Vermerris W (2017) Recent advances in nanomaterials for gene delivery—a review. Nano 7:94
Rodriguez A, Del A, Angeles M (2013) Non-viral delivery systems in gene therapy. In: Martin F (ed) Gene therapy - tools and potential applications. InTechOpen, London, pp 3–33. https://doi.org/10.5772/52704
Roller S, Covill N (1999) The antifungal properties of chitosan in laboratory media and apple juice. Int J Food Microbiol. https://doi.org/10.1016/S0168-1605(99)00006-9
Romano G, Micheli P, Pacilio C, Giordano A (2000) Latest developments in gene transfer technology: achievements, perspectives, and controversies over therapeutic applications. Stem Cells 18:19–39
Romøren K, Pedersen S, Smistad G, Evensen Ø, Thu BJ (2003) The influence of formulation variables on in vitro transfection efficiency and physicochemical properties of chitosan-based polyplexes. Int J Pharm. https://doi.org/10.1016/S0378-5173(03)00301-6
Rosenberg SA et al (1990) Gene transfer into humans — immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 323:570–578
Roth JA, Cristiano RJ (1997) Gene therapy for cancer: what have we done and where are we going? J Natl Cancer Inst 89:21–39
Roy K, Mao HQ, Huang SK, Leong KW (1999) Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 5:387–391
Rudzinski WE, Palacios A, Ahmed A, Lane MA, Aminabhavi TM (2016) Targeted delivery of small interfering RNA to colon cancer cells using chitosan and PEGylated chitosan nanoparticles. Carbohydr Polym 147:323–332
Ryu N et al (2018) Effective PEI-mediated delivery of CRISPR-Cas9 complex for targeted gene therapy. Nanomed Nanotechnol Biol Med 14:2095–2102
Sadeghpour H et al (2018) Double domain polyethylenimine-based nanoparticles for integrin receptor mediated delivery of plasmid DNA. Sci Rep 8:1–12
Sahay G, Alakhova DY, Kabanov AV (2010) Endocytosis of nanomedicines. J Control Release. https://doi.org/10.1016/j.jconrel.2010.01.036
Şalva E et al (2012) Local delivery of chitosan/VEGF siRNA nanoplexes reduces angiogenesis and growth of breast cancer In Vivo. Nucleic Acid Ther 22:40–48
Sanchez-Ramos J et al (2018) Chitosan-Mangafodipir nanoparticles designed for intranasal delivery of siRNA and DNA to brain. J Drug Deliv Sci Technol 43:453–460
Sashiwa H, Aiba SI (2004) Chemically modified chitin and chitosan as biomaterials. Prog Polym Sci 29:887–908
Sau S et al (2018) Multifunctional nanoparticles for cancer immunotherapy: a groundbreaking approach for reprogramming malfunctioned tumor environment. J Control Release 274:24–34
Sawaengsak C et al (2014) Intranasal chitosan-DNA vaccines that protect across influenza virus subtypes. Int J Pharm 473:113–125
Scallan CD, Tingley DW, Lindbloom JD, Toomey JS, Tucker SN (2013) An adenovirus-based vaccine with a double-stranded RNA adjuvant protects mice and ferrets against H5N1 avian influenza in oral delivery models. Clin Vaccine Immunol. https://doi.org/10.1128/CVI.00552-12
Scherer F et al (2002) Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther 9:102–109
Schuetz YB, Gurny R, Jordan O (2008) A novel thermoresponsive hydrogel based on chitosan. Eur J Pharm Biopharm 68:19–25
Sharma D, Singh J (2017) Synthesis and characterization of fatty acid grafted chitosan polymer and their nanomicelles for nonviral gene delivery applications. Bioconjug Chem 28:2772–2783
Sharma A et al (2011) Polyethylenimine-conjugated gold nanoparticles: gene transfer potential and low toxicity in the cornea. Nanomed Nanotechnol Biol Med 7:505–513
Sharma G et al (2013) Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: biodistribution and transfection. J Control Release 167:1–10
Shen ZP, Brayman AA, Chen L, Miao CH (2008) Ultrasound with microbubbles enhances gene expression of plasmid DNA in the liver via intraportal delivery. Gene Ther. https://doi.org/10.1038/gt.2008.51
Shi B et al (2017) Challenges in DNA delivery and recent advances in multifunctional polymeric DNA delivery systems. Biomacromolecules 18:2231–2246
Shi Q et al (2018) In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice. Int J Nanomedicine 13:387–402
Shu XZ, Zhu KJ (2002) The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release. Eur J Pharm Biopharm. https://doi.org/10.1016/S0939-6411(02)00052-8
Simon MJ, Gao S, Kang WH, Banta S, Morrison B (2009) TAT-mediated intracellular protein delivery to primary brain cells is dependent on glycosaminoglycan expression. Biotechnol Bioeng 104:10–19
Smaill F et al (2013) A human type 5 adenovirus-based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity. Sci Transl Med. https://doi.org/10.1126/scitranslmed.3006843
Song L et al (2018) Novel polyethyleneimine-R8-heparin nanogel for high-efficiency gene delivery in vitro and in vivo. Drug Deliv 25:122–131
Sonoda S et al (2006) Gene transfer to corneal epithelium and keratocytes mediated by ultrasound with microbubbles. Investig Ophthalmol Vis Sci. https://doi.org/10.1167/iovs.05-0889
Strand SP, Danielsen S, Christensen BE, Vårum KM (2005) Influence of chitosan structure on the formation and stability of DNA-chitosan polyelectrolyte complexes. Biomacromolecules 6:3357–3366
Stroes ES et al (2008) Intramuscular administration of AAV1-lipoprotein lipaseS447X lowers triglycerides in lipoprotein lipase-deficient patients. Arterioscler Thromb Vasc Biol. https://doi.org/10.1161/ATVBAHA.108.175620
Struszczyk MH (2002) Chitin and chitosan: part I. Properties and production. Polimery/Polymers 2:316
Su C-H, Wu Y-J, Wang H-H, Yeh H-I (2012) Nonviral gene therapy targeting cardiovascular system. AJP Hear Circ Physiol. https://doi.org/10.1152/ajpheart.00126.2012
Sugarman J (2015) Ethics and germline gene editing. EMBO Rep 16:879–880
Tae HK, Su IK, Akaike T, Chong SC (2005) Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes. J Control Release. https://doi.org/10.1016/j.jconrel.2005.03.024
Tahamtan A et al (2014) Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems. J Biomed Sci 21:69
Tahamtan A et al (2018) Antitumor immunity induced by genetic immunization with chitosan nanoparticle formulated Adjuvanted for HPV-16 E7 DNA vaccine. Iran J Immunol 15:269–280
Tharanathan RN, Kittur FS (2003) Chitin – the undisputed biomolecule of great potential. Crit Rev Food Sci Nutr. https://doi.org/10.1080/10408690390826455
Thibault M, Nimesh S, Lavertu M, Buschmann MD (2010) Intracellular trafficking and decondensation kinetics of chitosan-pDNA polyplexes. Mol Ther. https://doi.org/10.1038/mt.2010.143
Thomas CE, Ehrhardt A, Kay MA (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4:346–358
Valsalakumari J et al (2013) Novel gene delivery systems. Int J Pharm Investig 3:1
van Drunen Littel-van den Hurk S, Hannaman D (2010) Electroporation for DNA immunization: clinical application. Expert Rev Vaccines 9:503–517
Van Woensel M et al (2016) Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration. J Control Release 10:71–81
Varkouhi AK et al (2010) Gene silencing activity of siRNA polyplexes based on thiolated N, N, N -trimethylated chitosan. Bioconjug Chem. https://doi.org/10.1021/bc1003789
Varum KM, Ottoy MH, Smidsrod O (2001) Acid hydrolysis of chitosans. Carbohydr Polym 46:89–98
Vauthier C, Zandanel C, Ramon AL (2013) Chitosan-based nanoparticles for in vivo delivery of interfering agents including siRNA. Curr Opin Colloid Interface Sci. https://doi.org/10.1016/j.cocis.2013.06.005
Vollenweider RA (2000) Concerning calculation methods and limitations of proxy-estimates of proteins, carbohydrates and lipids in crustacean zooplankton from CHN analyses. J Limnol. https://doi.org/10.4081/jlimnol.2000.170
Voronina N et al (2016) Non-viral magnetic engineering of endothelial cells with microRNA and plasmid-DNA—an optimized targeting approach. Nanomed Nanotechnol Biol Med 12:2353–2364
Wang Y et al (2014) A magnetic nanoparticle-based multiple-gene delivery system for transfection of porcine kidney cells. PLoS One 9:1–9
Wang G-H et al (2018) TAT-conjugated chitosan cationic micelle for nuclear-targeted drug and gene co-delivery. Colloids Surf B: Biointerfaces 162:326–334
Wanjun T, Cunxin W, Donghua C (2005) Kinetic studies on the pyrolysis of chitin and chitosan. Polym Degrad Stab 87:389–394
Wasungu L, Hoekstra D (2006) Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release. https://doi.org/10.1016/j.jconrel.2006.06.024
Wedmore I, McManus JG, Pusateri AE, Holcomb JB (2006) A special report on the chitosan-based hemostatic dressing: experience in current combat operations. J Trauma – Inj Infect Crit Care 60:655–658
Wheeler JJ et al (1999) Stabilized plasmid-lipid particles: construction and characterization. Gene Ther. https://doi.org/10.1038/sj.gt.3300821
Whinnery C, Kirsch WM (2016) Recent advances in chitosan-based gene carrier application and design. JSM Biochem Mol Biol 3
Wilson JM (2009) Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency. Mol Genet Metab. https://doi.org/10.1016/j.ymgme.2008.12.016
Wolschek MF et al (2002) Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice. Hepatology. https://doi.org/10.1053/jhep.2002.36372
Wu LQ et al (2002) Voltage-dependent assembly of the polysaccharide chitosan onto an electrode surface. Langmuir. https://doi.org/10.1021/la020381p
Wu G et al (2018) In situ controlled release of stromal cell-derived factor-1α and antimiR-138 for on-demand cranial bone regeneration. Carbohydr Polym 182:215–224
Xu J, McCarthy SP, Gross RA, Kaplan DL (1996) Chitosan film acylation and effects on biodegradability. Macromolecules. https://doi.org/10.1021/ma951638b
Xu T, Xin M, Li M, Huang H, Zhou S (2010) Synthesis, characteristic and antibacterial activity of N,N,N-trimethyl chitosan and its carboxymethyl derivatives. Carbohydr Polym 81:931–936
Yamano S et al (2011) Modified tat peptide with cationic lipids enhances gene transfection efficiency via temperature-dependent and caveolae-mediated endocytosis. J Control Release 152:278–285
Yamano S et al (2014) Long-term efficient gene delivery using polyethylenimine with modified tat peptide. Biomaterials 35:1705–1715
Yang NS, Burkholder J, Roberts B, Martinell B, McCabe D (1990) In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. PNAS. https://doi.org/10.1073/pnas.87.24.9568
Yang YM, Hu W, Wang XD, Gu XS (2007) The controlling biodegradation of chitosan fibers by N-acetylation in vitro and in vivo. J Mater Sci Mater Med 18:2117–2121
Yang F et al (2013) Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles. Biomaterials 34:5689–5699
Yhee JY et al (2015) Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance. J Control Release 198:1–9
Yigit S, Tokareva O, Varone A, Georgakoudi I, Kaplan DL (2014) Bioengineered silk gene delivery system for nuclear targeting. Macromol Biosci 14:1291–1298
Yin H et al (2014) Non-viral vectors for gene-based therapy. Nat Rev Genet 15:541–555
Zai W et al (2019) Targeted Interleukin-22 gene delivery in the liver by polymetformin and penetratin-based hybrid nanoparticles to treat nonalcoholic fatty liver disease. ACS Appl Mater Interfaces. https://doi.org/10.1021/acsami.8b19717
Zhang Y et al (2004a) Intravenous RNA interference gene therapy targeting the human epidermal growth factor receptor prolongs survival in intracranial brain cancer. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-03-0740
Zhang S, Xu Y, Wang B, Qiao W, Liu D (2004b) Cationic compounds used in lipoplexes and polyplexes for gene delivery. J Control Release 100:165–180
Zhang J et al (2010) Chitosan modification and pharmaceutical/biomedical applications. Mar Drugs 8:1962–1987
Zhang Y, Satterlee A, Huang L (2012) In vivo gene delivery by nonviral vectors: overcoming hurdles. Mol Ther 20:1298–1304
Zhang Y, Li N, Suh H, Irvine DJ (2018) Nanoparticle anchoring targets immune agonists to tumors enabling anti-cancer immunity without systemic toxicity. Nat Commun 9
Zhao K et al (2011) Preparation and immunological effectiveness of a swine influenza DNA vaccine encapsulated in chitosan nanoparticles. Vaccine 29:8549–8556
Zheng L-Y, Zhu J-F (2003) Study on antimicrobial activity of chitosan with different molecular weights. Carbohydr Polym 54:527–530
Zhou P et al (2018) Chondroprotective effects of hyaluronic acid-chitosan nanoparticles containing plasmid DNA encoding cytokine response modifier a in a rat knee osteoarthritis model. Cell Physiol Biochem 47:1207–1216
Zylberberg C, Gaskill K, Pasley S, Matosevic S (2017) Engineering liposomal nanoparticles for targeted gene therapy. Gene Ther 24:441–452
Acknowledgments
We would like to acknowledge the funding support from the National Institutes of Health (NIH) grant # RO1AG051574.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Sharma, D., Arora, S., dos Santos Rodrigues, B., Lakkadwala, S., Banerjee, A., Singh, J. (2019). Chitosan-Based Systems for Gene Delivery. In: Jana, S., Jana, S. (eds) Functional Chitosan. Springer, Singapore. https://doi.org/10.1007/978-981-15-0263-7_8
Download citation
DOI: https://doi.org/10.1007/978-981-15-0263-7_8
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-0262-0
Online ISBN: 978-981-15-0263-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)